MedTrace Logo

Herpes Zoster Hospitalizations in Italy

NCT05952271 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 72000

Last updated 2023-10-27

No results posted yet for this study

Summary

In Italy, the 2017-2019 National Immunization Plan recommended specific vaccinations for the elderly, defined as those 65 years old and older, and at-risk adults with age 50+ (adults presenting cardiovascular, respiratory, or metabolic diseases, immunodepression, etc.). However, the coverage target set by the Plan (50% for Herpes Zoster vaccination in 2019) was not reached.

Providing additional data on the incidence of Herpes Zoster could improve the risks perception of the disease and the vaccination uptake. The present study will aim to describe a full picture of Herpes Zoster associated hospital admissions in Italy, focusing on co-morbidities which induce reduced varicella-zoster virus-specific cell-mediated immunity response. Furthermore, as varicella-zoster virus reactivation was reported in COVID-19-positive patients, a deepening on a possible relationship between the two infections will be investigated.

Conditions

  • Herpes Zoster
  • Comorbidities and Coexisting Conditions

Interventions

OTHER

Hospitalization

Population of patients hospitalized for Herpes Zoster (ICD9-CM 053.xx)

Sponsors & Collaborators

Principal Investigators

  • Antonella Mattei, PhD · University of L'Aquila

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-26
Primary Completion
2024-04-01
Completion
2025-07-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05952271 on ClinicalTrials.gov